Phase III Clinical Trial, - To estimate the consistency between Allergen Scratch Extract "Torii" Mite skin test result and TO-205 skin test result of same patient with allergy -

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222061

Enrollment

Registered

2013-04-16

Start date

2013-04-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perennial allergic rhinitis or asthma

Interventions

investigational material(s) Generic name etc : TO-205 INN of investigational material : Therapeutic category code : 729 Other diagnostic agents (except extracorporeal diagnostic medicines) Dosage and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Rhinitis : Patients with perennial rhinitis symptom or treatmet of perennial rhinits for more than 6 months Asthma : Patients with asthma symptom or treatmet of asthma for more than 6 months

Exclusion criteria

Exclusion criteria: 1) Patients with identified causative allergen informatoin 2) Patients with treatmetn to affect skin test result, for example anti-histamine drug

Design outcomes

Primary

Measure	Time frame
efficacy	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026